$ANF
ABERCROMBIE & FITCH CO /DE/ Stock $anf

$anf Overview Financials Valuation SEC Filings Company Website

2012 Q2 Form 10-Q Financial Statement

#000119312512260342 Filed on June 05, 2012

Income Statement

Concept	2012 Q2	2012 Q1	2011 Q2
Revenue	$921.2M	$1.329B	$836.7M
YoY Change	10.1%	15.61%	21.64%
Cost Of Revenue	$380.1M	$551.8M	$293.0M
YoY Change	29.73%	31.88%	14.28%
Gross Profit	$541.1M	$790.0M	$525.5M
YoY Change	2.96%	8.07%	21.82%
Gross Profit Margin	58.74%	59.45%	62.81%
Selling, General & Admin	$572.6M	$713.8M	$506.8M
YoY Change	12.98%	31.36%	12.37%
% of Gross Profit	105.82%	90.36%	96.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$54.50M	$59.40M	$57.20M
YoY Change	-4.72%	-3.26%	0.88%
% of Gross Profit	10.07%	7.52%	10.88%
Operating Expenses	$572.6M	$721.4M	$504.9M
YoY Change	13.41%	34.11%	12.18%
Operating Profit	-$28.95M	$68.57M	$38.75M
YoY Change	-174.71%	-64.49%	-307.06%
Interest Expense	$600.0K	-$1.000M	-$1.000M
YoY Change	-160.0%	-9.09%	25.0%
% of Operating Profit		-1.46%	-2.58%
Other Income/Expense, Net	$1.900M	-$100.0K	$100.0K
YoY Change	1800.0%
Pretax Income	-$30.03M	$54.50M	$37.80M
YoY Change	-179.47%	-62.05%	-293.45%
Income Tax	-$8.700M	$18.60M	$13.50M
% Of Pretax Income		34.13%	35.72%
Net Earnings	-$21.31M	$45.83M	$13.00M
YoY Change	-263.91%	-50.51%	-209.89%
Net Earnings / Revenue	-2.31%	3.45%	1.55%
Basic Earnings Per Share	-$0.25		$0.29
Diluted Earnings Per Share	-$0.25	$0.52	$0.14
COMMON SHARES
Basic Shares Outstanding	84.59M shares	84.72M shares	87.28M shares
Diluted Shares Outstanding	84.59M shares		90.44M shares

Balance Sheet

Concept	2012 Q2	2012 Q1	2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$359.5M	$668.1M	$741.8M
YoY Change	-51.54%	-19.16%	17.23%
Cash & Equivalents	$321.6M	$583.5M	$745.6M
Short-Term Investments	$37.90M	$84.70M	$0.00
Other Short-Term Assets	$83.39M	$84.34M	$95.09M
YoY Change	-12.31%	6.24%	-33.97%
Inventory	$592.2M	$679.9M	$358.4M
Prepaid Expenses
Receivables	$73.40M	$89.40M	$78.20M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.110B	$1.558B	$1.340B
YoY Change	-17.16%	9.17%	13.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.267B	$1.197B	$1.162B
YoY Change	9.03%	3.68%	-3.92%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$14.90M	$101.6M
YoY Change	-100.0%	-85.17%	-27.58%
Other Assets	$357.4M	$347.2M	$290.0M
YoY Change	23.23%	33.9%	42.16%
Total Long-Term Assets	$1.624B	$1.559B	$1.553B
YoY Change	4.56%	2.95%	-0.01%
TOTAL ASSETS
Total Short-Term Assets	$1.110B	$1.558B	$1.340B
Total Long-Term Assets	$1.624B	$1.559B	$1.553B
Total Assets	$2.734B	$3.117B	$2.893B
YoY Change	-5.5%	5.97%	5.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$160.2M	$211.4M	$151.4M
YoY Change	5.79%	54.02%	37.54%
Accrued Expenses	$323.6M	$369.1M	$263.3M
YoY Change	22.9%	22.98%	25.2%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$545.2M	$699.4M	$491.8M
YoY Change	10.86%	26.62%	18.27%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$69.87M
YoY Change	-100.0%	-100.0%	-1.03%
Other Long-Term Liabilities	$247.0M	$245.4M	$206.2M
YoY Change	19.77%	20.56%	-49.13%
Total Long-Term Liabilities	$495.8M	$486.3M	$492.7M
YoY Change	0.63%	-2.4%	3.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$545.2M	$699.4M	$491.8M
Total Long-Term Liabilities	$495.8M	$486.3M	$492.7M
Total Liabilities	$1.041B	$1.186B	$984.4M
YoY Change	5.74%	12.86%	4.95%
SHAREHOLDERS EQUITY
Retained Earnings	$2.309B	$2.390B	$2.282B
YoY Change	1.16%	5.16%
Common Stock	$368.4M	$370.2M	$344.1M
YoY Change	7.05%	5.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$986.6M	$834.8M	$727.1M
YoY Change	35.69%	15.09%
Treasury Stock Shares	20.76M shares	17.66M shares	15.92M shares
Shareholders Equity	$1.693B	$1.931B	$1.909B
YoY Change
Total Liabilities & Shareholders Equity	$2.734B	$3.117B	$2.893B
YoY Change	-5.5%	5.97%	5.64%

Cashflow Statement

Concept	2012 Q2	2012 Q1	2011 Q2
OPERATING ACTIVITIES
Net Income	-$21.31M	$45.83M	$13.00M
YoY Change	-263.91%	-50.51%	-209.89%
Depreciation, Depletion And Amortization	$54.50M	$59.40M	$57.20M
YoY Change	-4.72%	-3.26%	0.88%
Cash From Operating Activities	-$44.51M	$305.5M	-$10.17M
YoY Change	337.59%	-2.8%	-71.89%
INVESTING ACTIVITIES
Capital Expenditures	$103.8M	-$91.00M	$51.50M
YoY Change	101.59%	107.29%	168.14%
Acquisitions
YoY Change
Other Investing Activities	$4.121M	-$1.500M	$0.00
YoY Change		-110.2%	-100.0%
Cash From Investing Activities	-$45.51M	-$92.60M	-$51.38M
YoY Change	-11.41%	214.97%	243.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$159.1M		$25.47M
YoY Change	524.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$174.4M	-113.2M	-$29.45M
YoY Change	492.26%	65.5%	73.21%
NET CHANGE
Cash From Operating Activities	-$44.51M	305.5M	-$10.17M
Cash From Investing Activities	-$45.51M	-92.60M	-$51.38M
Cash From Financing Activities	-$174.4M	-113.2M	-$29.45M
Net Change In Cash	-$264.5M	99.70M	-$91.00M
YoY Change	190.61%	-53.95%	33.56%
FREE CASH FLOW
Cash From Operating Activities	-$44.51M	$305.5M	-$10.17M
Capital Expenditures	$103.8M	-$91.00M	$51.50M
Free Cash Flow	-$148.3M	$396.5M	-$61.67M
YoY Change	140.52%	10.69%	11.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2694000	USD
CY2012Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.175
CY2012Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	3384000	USD
CY2011Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2012Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2985000	USD
CY2012Q2	us-gaap	Profit Loss ProfitLoss	2985000	USD
CY2012Q2	dei	Entity Registrant Name EntityRegistrantName	ABERCROMBIE & FITCH CO /DE/
CY2012Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001018840
CY2012Q2	dei	Document Type DocumentType	10-Q
CY2012Q2	dei	Document Period End Date DocumentPeriodEndDate	2012-04-28
CY2012Q2	dei	Amendment Flag AmendmentFlag	false
CY2012Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-03
CY2012Q2	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2012Q2	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2012Q2	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2012Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2012Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82553044	shares
CY2011Q3	dei	Entity Public Float EntityPublicFloat	6358940247	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	921218000	USD
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	344859000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	576359000	USD
CY2012Q2	anf	Stores And Distribution Expense StoresAndDistributionExpense	455732000	USD
CY2012Q2	anf	Marketing General And Administrative Expense MarketingGeneralAndAdministrativeExpense	116889000	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	6322000	USD
CY2012Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1089000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5233000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit Continuing Operations IncomeTaxExpenseBenefitContinuingOperations	2248000	USD
CY2012Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	323573000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	321617000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6455000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.28
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.03
CY2011Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.27
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2012Q2	us-gaap	Other Comprehensive Income Available For Sale Securities Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease	0	USD
CY2012Q2	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease	-7145000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	-3761000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-776000	USD
CY2011Q2	us-gaap	Sales Revenue Net SalesRevenueNet	836674000	USD
CY2011Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	293013000	USD
CY2011Q2	us-gaap	Gross Profit GrossProfit	543661000	USD
CY2011Q2	anf	Stores And Distribution Expense StoresAndDistributionExpense	399101000	USD
CY2011Q2	anf	Marketing General And Administrative Expense MarketingGeneralAndAdministrativeExpense	107651000	USD
CY2011Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	38745000	USD
CY2011Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-950000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	37795000	USD
CY2011Q2	us-gaap	Income Tax Expense Benefit Continuing Operations IncomeTaxExpenseBenefitContinuingOperations	13450000	USD
CY2011Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	24345000	USD
CY2011Q2	us-gaap	Profit Loss ProfitLoss	25141000	USD
CY2011Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.175
CY2011Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	18487000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Available For Sale Securities Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease	665000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease	-3247000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Period Increase Decrease OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease	15905000	USD
CY2011Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	41046000	USD
CY2011Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	796000	USD
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2011Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2011Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.04
CY2011Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.28
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	84593000	shares
CY2011Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87282000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86184000	shares
CY2011Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	90441000	shares
CY2012Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2584000	USD
CY2011Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	1836000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Tax Effect Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxEffectPeriodIncreaseDecrease	936000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Available For Sale Securities Tax OtherComprehensiveIncomeAvailableForSaleSecuritiesTax	0	USD
CY2011Q2	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Tax Effect Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxEffectPeriodIncreaseDecrease	1907000	USD
CY2011Q2	us-gaap	Other Comprehensive Income Available For Sale Securities Tax OtherComprehensiveIncomeAvailableForSaleSecuritiesTax	-390000	USD
CY2011	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Tax Effect Period Increase Decrease OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxEffectPeriodIncreaseDecrease	0	USD
CY2011	us-gaap	Other Comprehensive Income Available For Sale Securities Tax OtherComprehensiveIncomeAvailableForSaleSecuritiesTax	0	USD
CY2012Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	73429000	USD
CY2012Q2	us-gaap	Inventory Net InventoryNet	517564000	USD
CY2012Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	75775000	USD
CY2012Q2	us-gaap	Other Assets Current OtherAssetsCurrent	83386000	USD
CY2012Q2	us-gaap	Assets Current AssetsCurrent	1109673000	USD
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1266875000	USD
CY2012Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	0	USD
CY2012Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	357393000	USD
CY2012Q2	us-gaap	Assets Assets	2733941000	USD
CY2012Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	160203000	USD
CY2012Q2	anf	Deferred Lease Credits Current DeferredLeaseCreditsCurrent	41544000	USD
CY2012Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	19850000	USD
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	545170000	USD
CY2012Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2012Q2	anf	Deferred Lease Credits Noncurrent DeferredLeaseCreditsNoncurrent	183066000	USD
CY2012Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2012Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	246982000	USD
CY2012Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	495756000	USD
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	1033000	USD
CY2012Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	367352000	USD
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2308546000	USD
CY2012Q2	us-gaap	Treasury Stock Value TreasuryStockValue	986610000	USD
CY2012Q2	us-gaap	Stockholders Equity StockholdersEquity	1693015000	USD
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2733941000	USD
CY2012Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	211368000	USD
CY2012Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2320571000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	583495000	USD
CY2012Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	369073000	USD
CY2012Q1	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	14858000	USD
CY2012Q1	anf	Deferred Lease Credits Current DeferredLeaseCreditsCurrent	41047000	USD
CY2012Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	347249000	USD
CY2012Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	486291000	USD
CY2012Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	369171000	USD
CY2012Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	77918000	USD
CY2012Q1	us-gaap	Treasury Stock Value TreasuryStockValue	834774000	USD
CY2012Q1	us-gaap	Inventory Net InventoryNet	569818000	USD
CY2012Q1	us-gaap	Liabilities Current LiabilitiesCurrent	699406000	USD
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	1033000	USD
CY2012Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	4123000	USD
CY2012Q1	us-gaap	Stockholders Equity StockholdersEquity	1862456000	USD
CY2012Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	241295000	USD
CY2012Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	77120000	USD
CY2012Q1	us-gaap	Other Assets Current OtherAssetsCurrent	84342000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1197271000	USD
CY2012Q1	anf	Deferred Lease Credits Noncurrent DeferredLeaseCreditsNoncurrent	183022000	USD
CY2012Q1	us-gaap	Assets Assets	3048153000	USD
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3048153000	USD
CY2012Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2012Q1	us-gaap	Assets Current AssetsCurrent	1488775000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	826353000	USD
CY2012Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	89350000	USD
CY2012Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	84650000	USD
CY2012Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	37902000	USD
CY2012Q2	anf	Leasehold Financing Obligations Non Current Liabilities LeaseholdFinancingObligationsNonCurrentLiabilities	65708000	USD
CY2012Q1	anf	Leasehold Financing Obligations Non Current Liabilities LeaseholdFinancingObligationsNonCurrentLiabilities	57851000	USD
CY2012Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	17662000	shares
CY2012Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	20758000	shares
CY2011Q2	us-gaap	Share Based Compensation ShareBasedCompensation	10852000	USD
CY2011Q2	anf	Amortization Of Deferred Lease Credits AmortizationOfDeferredLeaseCredits	-10710000	USD
CY2011Q2	anf	Less Or Construction Allowances LessOrConstructionAllowances	-4548000	USD
CY2011Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	108000	USD
CY2011Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	57218000	USD
CY2011Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2452000	USD
CY2011Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2011Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-28803000	USD
CY2011Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-52645000	USD
CY2011Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	31350000	USD
CY2011Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10172000	USD
CY2011Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-34489000	USD
CY2011Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	51501000	USD
CY2011Q2	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	0	USD
CY2011Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	125000	USD
CY2011Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2011Q2	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	9084000	USD
CY2011Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	25469000	USD
CY2011Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2011Q2	anf	Change In Outstanding Checks And Other ChangeInOutstandingChecksAndOther	-869000	USD
CY2011Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	15292000	USD
CY2011Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-29452000	USD
CY2011Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	6470000	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-84530000	USD
CY2011Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	745570000	USD
CY2011Q2	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	10674000	USD
CY2012Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44512000	USD
CY2012Q2	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	99000	USD
CY2012Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-174431000	USD
CY2012Q2	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	159065000	USD
CY2012Q2	us-gaap	Share Based Compensation ShareBasedCompensation	12817000	USD
CY2012Q2	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-57971000	USD
CY2012Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	14813000	USD
CY2012Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	84000	USD
CY2012Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-5555000	USD
CY2012Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	54547000	USD
CY2012Q2	anf	Less Or Construction Allowances LessOrConstructionAllowances	-4865000	USD
CY2012Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2694000	USD
CY2012Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2012Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-52724000	USD
CY2012Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2577000	USD
CY2012Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	103822000	USD
CY2012Q2	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4121000	USD
CY2012Q2	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2012Q2	anf	Amortization Of Deferred Lease Credits AmortizationOfDeferredLeaseCredits	-11998000	USD
CY2012Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-106920000	USD
CY2012Q2	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	4241000	USD
CY2012Q2	anf	Change In Outstanding Checks And Other ChangeInOutstandingChecksAndOther	1717000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-261878000	USD
CY2012Q2	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	0	USD
CY2012Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	62431000	USD
CY2012Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45512000	USD
CY2011Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-51376000	USD
CY2012Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1065000	USD
CY2011Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1356000	USD
CY2012Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1065000	USD
CY2011Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1356000	USD
CY2012Q2	anf	Current Deferred Income Tax Expense Benefit CurrentDeferredIncomeTaxExpenseBenefit	2661000	USD
CY2011Q2	anf	Current Deferred Income Tax Expense Benefit CurrentDeferredIncomeTaxExpenseBenefit	8528000	USD
CY2012Q2	anf	Companys Fiscal Period CompanysFiscalPeriod	53-week fiscal year
CY2012	anf	Companys Fiscal Period CompanysFiscalPeriod	52-week fiscal year
CY2012Q2	us-gaap	Prior Period Reclassification Adjustment PriorPeriodReclassificationAdjustment	1300000	USD
CY2012Q2	us-gaap	Noncurrent Assets NoncurrentAssets	1388455000	USD
CY2011Q2	us-gaap	Noncurrent Assets NoncurrentAssets	1317731000	USD
CY2012Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12800000	USD
CY2011Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10900000	USD
CY2011Q2	anf	Share Based Compensation Expense Effect Of Adjustment For Forfeitures ShareBasedCompensationExpenseEffectOfAdjustmentForForfeitures	1700000	USD
CY2012Q2	anf	Share Based Compensation Arrangement By Share Based Payment Award Number Of Primary Compensation Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPrimaryCompensationPlans	2	pure
CY2012Q2	anf	Share Based Compensation Arrangement By Share Based Payment Award Number Of Other Compensation Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfOtherCompensationPlans	4	pure
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	714997	shares
CY2012Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-3750	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	60.72
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	26.60
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	711247	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	60.90
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4552433	USD
CY2012Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	4.3
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	695247	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	61.83
CY2012Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4067823	USD
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	4.2
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm	6.6
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	468174	USD
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	20.58
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	15454	shares
CY2012Q2	anf	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalFairValue	1200000	USD
CY2011Q2	anf	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalFairValue	2200000	USD
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.00	pure
CY2011Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5883000	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1189292	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	502025	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-304256	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-108106	shares
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1278955	shares
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	49.11
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue	59.77
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	48.06
CY2012Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	50.62
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3801000	shares
CY2012Q2	us-gaap	Cash Cash	321603000	USD
CY2012Q1	us-gaap	Cash Cash	374479000	USD
CY2012Q2	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	18707000	shares
CY2011Q2	us-gaap	Weighted Average Number Of Shares Treasury Stock WeightedAverageNumberOfSharesTreasuryStock	16018000	shares
CY2012Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1591000	shares
CY2011Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3159000	shares
CY2011Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	103300000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	103300000	shares
CY2012Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	14000	USD
CY2012Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	209016000	USD
CY2012Q2	anf	Maturity Period Of Cash Equivalents MaturityPeriodOfCashEquivalents	3 months
CY2012Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	28900000	USD
CY2012Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	30000000	USD
CY2012Q2	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	85980000	USD
CY2012Q2	us-gaap	Investments Investments	123882000	USD
CY2012Q1	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	85149000	USD
CY2012Q1	us-gaap	Investments Investments	184657000	USD
CY2012Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	37902000	USD
CY2012Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	99508000	USD
CY2012Q2	anf	Available For Sale Securities Debt Securities Noncurrent Par Value AvailableForSaleSecuritiesDebtSecuritiesNoncurrentParValue	45175000	USD
CY2012Q2	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	-7273000	USD
CY2012Q2	us-gaap	Heldtomaturity Securities Debt Maturity Date Range Low HeldtomaturitySecuritiesDebtMaturityDateRangeLow	22 years
CY2012Q2	us-gaap	Heldtomaturity Securities Debt Maturity Date Range High HeldtomaturitySecuritiesDebtMaturityDateRangeHigh	29 years
CY2012Q2	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	800000	USD
CY2011Q2	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	700000	USD
CY2012Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	99508000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Sales Issuances Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements	-62431000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	37902000	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncome	0	USD
CY2012Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings	825000	USD
CY2012Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	34700000	USD
CY2012Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	72300000	USD
CY2011Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	39200000	USD
CY2012Q2	anf	Inventory Shrink Reserve InventoryShrinkReserve	7100000	USD
CY2012Q1	anf	Inventory Shrink Reserve InventoryShrinkReserve	9300000	USD
CY2011Q2	anf	Inventory Shrink Reserve InventoryShrinkReserve	5600000	USD
CY2011Q2	us-gaap	Inventory Net InventoryNet	358400000	USD
CY2012Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2766092000	USD
CY2012Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1499217000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2655219000	USD
CY2012Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1457948000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Fair Value Disclosure PropertyPlantAndEquipmentFairValueDisclosure	13100000	USD
CY2012Q2	anf	Deferred Lease Credits Gross DeferredLeaseCreditsGross	553105000	USD
CY2012Q2	anf	Amortized Deferred Lease Credits Accumulated AmortizedDeferredLeaseCreditsAccumulated	328495000	USD
CY2012Q2	anf	Deferred Lease Credits Net DeferredLeaseCreditsNet	224610000	USD
CY2012Q1	anf	Deferred Lease Credits Net DeferredLeaseCreditsNet	224069000	USD
CY2012Q1	anf	Deferred Lease Credits Gross DeferredLeaseCreditsGross	551468000	USD
CY2012Q1	anf	Amortized Deferred Lease Credits Accumulated AmortizedDeferredLeaseCreditsAccumulated	327399000	USD
CY2012Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.43	pure
CY2011Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.356	pure
CY2012Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	70100000	USD
CY2011Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	67300000	USD
CY2012Q2	anf	Leverage Ratio LeverageRatio	6	pure
CY2011Q2	anf	Leasehold Financing Obligations LeaseholdFinancingObligations	13. LEASEHOLD FINANCING OBLIGATIONS As of April 28, 2012 and January 28, 2012, the Company had $65.7 million and $57.9 million, respectively, of long-term debt related to the landlord financing obligation. In certain lease arrangements, the Company is involved with the construction of the building. If the Company determines that it has substantially all of the risks of ownership during construction of the leased property and therefore is deemed to be the owner of the construction project, the Company records an asset and related financing obligation for the amount of the total project costs and an amount related to the pre-existing, leased building, which is included in Property and Equipment, Net and Leasehold Financing Obligations, respectively, on the Consolidated Balance Sheets. Once construction is complete, the Company determines if the asset qualifies for sale-leaseback accounting treatment. If the arrangement does not qualify for sale-lease back treatment, the Company continues to amortize the obligation over the lease term and depreciates the asset over its useful life. The Company does not report rent expense for the portion of the rent payment determined to be related to the properties which are owned for accounting purposes. Rather, this portion of the rental payments under the lease are recognized as a reduction of the financing obligation and interest expense. Total interest expense was $2.2 million for both the thirteen weeks ended April 28, 2012 and April 30, 2011.
CY2012Q2	anf	Landlord Financing Obligation LandlordFinancingObligation	65700000	USD
CY2012Q1	anf	Landlord Financing Obligation LandlordFinancingObligation	57900000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	2200000	USD
CY2012Q2	anf	Maximum Length Of Time Inventory Sales Hedged MaximumLengthOfTimeInventorySalesHedged	12 months
CY2012Q2	anf	Additional Time Period In Which Forecasted Transaction Is Not Expected To Occur AdditionalTimePeriodInWhichForecastedTransactionIsNotExpectedToOccur	2 months
CY2012Q2	anf	Period In Which Intercompany Inventory Sales Recognized PeriodInWhichIntercompanyInventorySalesRecognized	2 months
CY2012Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	5597000	USD
CY2012Q2	anf	Number Of Stores Closed NumberOfStoresClosed	29	pure
CY2012Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	10770000	USD
CY2012Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	2632000	USD
CY2012Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1458000	USD
CY2012Q2	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	1100000	USD
CY2011Q2	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	600000	USD
CY2011Q2	anf	Deferred Compensation With Individual Percentage Of Monthly Compensation Benefit DeferredCompensationWithIndividualPercentageOfMonthlyCompensationBenefit	0.5	pure
CY2012Q2	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:12pt;margin-left:0px;">18. RECENT ACCOUNTING PRONOUNCEMENTS</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:12pt;margin-left:0px;">Accounting Standards Codification 820-10</font><font style="font-family:Times New Roman;font-size:12pt;">,</font><font style="font-family:Times New Roman;font-size:12pt;"> “Fair Val</font><font style="font-family:Times New Roman;font-size:12pt;">ue Measurements and Disclosures</font><font style="font-family:Times New Roman;font-size:12pt;">” (“ASC 820-10”) was amended in January 2010 to require additional disclosures related to recurring and nonrecurring fair value measurements. The guidance requires disclosure of transfers of assets and liabilities between Levels 1 and 2 of the fair value hierarchy, including the reasons </font><font style="font-family:Times New Roman;font-size:12pt;">and the timing of the transfers;</font><font style="font-family:Times New Roman;font-size:12pt;"> and information on purchases, sales, issuances, and settlements on a gross basis in the reconciliation of the assets and liabilities measured under Level 3 of the fair value hierarchy. The guidance was effective for the Company beginning on </font><font style="font-family:Times New Roman;font-size:12pt;">January 31, 2010. The</font><font style="font-family:Times New Roman;font-size:12pt;"> disclosure guidance adopted on </font><font style="font-family:Times New Roman;font-size:12pt;">January 31, 2010,</font><font style="font-family:Times New Roman;font-size:12pt;"> did not have a material impact on our consolidated financial statements</font><font style="font-family:Times New Roman;font-size:12pt;">.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:12pt;margin-left:0px;">In May 2011, ASC 820-10 was further amended to clarify certain disclosure requirements and improve consistency with international reporting standards. This amendment is to be applied prosp</font><font style="font-family:Times New Roman;font-size:12pt;">ectively and became</font><font style="font-family:Times New Roman;font-size:12pt;"> effective for the Company beginning January 2</font><font style="font-family:Times New Roman;font-size:12pt;">9</font><font style="font-family:Times New Roman;font-size:12pt;">, 2012. The adoption </font><font style="font-family:Times New Roman;font-size:12pt;">did not</font><font style="font-family:Times New Roman;font-size:12pt;"> have a material effect on </font><font style="font-family:Times New Roman;font-size:12pt;">our</font><font style="font-family:Times New Roman;font-size:12pt;"> consolidated financial statements.</font></p><p style='margin-top:0pt; margin-bottom:0pt'> </p><p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:12pt;margin-left:0px;">Accounting Standards Codification Topic 220, “Comprehensive Income,”</font><font style="font-family:Times New Roman;font-size:12pt;"> was amended </font><font style="font-family:Times New Roman;font-size:12pt;">in June 2011 to </font><font style="font-family:Times New Roman;font-size:12pt;">require entities to present the </font><font style="font-family:Times New Roman;font-size:12pt;">tot</font><font style="font-family:Times New Roman;font-size:12pt;">al of comprehensive income, the </font><font style="font-family:Times New Roman;font-size:12pt;">components of net income, and the components of other</font><font style="font-family:Times New Roman;font-size:12pt;"> comprehensive income either in </font><font style="font-family:Times New Roman;font-size:12pt;">a single</font><font style="font-family:Times New Roman;font-size:12pt;"> </font><font style="font-family:Times New Roman;font-size:12pt;">continuous statement of comprehensiv</font><font style="font-family:Times New Roman;font-size:12pt;">e income or in two separate but </font><font style="font-family:Times New Roman;font-size:12pt;">consecutive statements. The amendment does not change the</font><font style="font-family:Times New Roman;font-size:12pt;"> </font><font style="font-family:Times New Roman;font-size:12pt;">items that must be reported in other comprehensive income or when an item of other comprehensive income must be reclassified to</font><font style="font-family:Times New Roman;font-size:12pt;"> </font><font style="font-family:Times New Roman;font-size:12pt;">net income under current </font><font style="font-family:Times New Roman;font-size:12pt;">U.S. </font><font style="font-family:Times New Roman;font-size:12pt;">GAAP. Thi</font><font style="font-family:Times New Roman;font-size:12pt;">s guidance became</font><font style="font-family:Times New Roman;font-size:12pt;"> effective for the </font><font style="font-family:Times New Roman;font-size:12pt;">Company's fiscal year and interim periods beginning January 29,</font><font style="font-family:Times New Roman;font-size:12pt;"> </font><font style="font-family:Times New Roman;font-size:12pt;">2012. The adoption </font><font style="font-family:Times New Roman;font-size:12pt;">did not </font><font style="font-family:Times New Roman;font-size:12pt;">have a material effec</font><font style="font-family:Times New Roman;font-size:12pt;">t on our </font><font style="font-family:Times New Roman;font-size:12pt;">consolidated financial </font><font style="font-family:Times New Roman;font-size:12pt;">statements.</font><font style="font-family:Times New Roman;font-size:12pt;"> </font></p>

Files In Submission

Name	View Source	Status
0001193125-12-260342-index-headers.html	Edgar Link	pending
0001193125-12-260342-index.html	Edgar Link	pending
0001193125-12-260342.txt	Edgar Link	pending
0001193125-12-260342-xbrl.zip	Edgar Link	pending
anf-20120428.xml	Edgar Link	completed
anf-20120428.xsd	Edgar Link	pending
anf-20120428_cal.xml	Edgar Link	unprocessable
anf-20120428_def.xml	Edgar Link	unprocessable
anf-20120428_lab.xml	Edgar Link	unprocessable
anf-20120428_pre.xml	Edgar Link	unprocessable
d359946d10q.htm	Edgar Link	pending
d359946dex15.htm	Edgar Link	pending
d359946dex311.htm	Edgar Link	pending
d359946dex312.htm	Edgar Link	pending
d359946dex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ANF
ABERCROMBIE & FITCH CO /DE/ Stock $anf

2012 Q2 Form 10-Q Financial Statement

#000119312512260342 Filed on June 05, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANF ABERCROMBIE & FITCH CO /DE/ Stock $anf

2012 Q2 Form 10-Q Financial Statement

#000119312512260342 Filed on June 05, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANF
ABERCROMBIE & FITCH CO /DE/ Stock $anf